Sep 22,2022

my mhealth announces appointment of David Pettigrew as their new CEO

my mhealth, a leading Digital Therapeutics (DTx) company based in the UK, is pleased to announce the promotion of Dr. David Pettigrew as CEO. David will guide the organisation in its mission to improve the quality of care for people with long term conditions, through digital health. Having spent time in the US successfully growing a healthcare technology business for a UK-based company, David is ideally placed to lead my mhealth’s expansion into the US market.

View Analyst & Ambassador Comments
Go to original news
Sep 22,2022

DarioHealth Publishes New Clinical Research Linking the Use of its Biofeedback Device to Reduced Back Pain

DarioHealth Corp., a leader in the global digital therapeutics (DTx) market, announced today new research examining the link between the use of Dario's biofeedback device to help users improve their posture and reduced back pain at the International Association of the Study of Pain (IASP) 2022 World Congress on Pain, being held in person in Toronto, Ontario from September 19th – 23rd and virtually.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Sep 22,2022

Limbo is tackling obesity with a pair of wearables and decades of physiology

Limbo, a New York, London and Cork-based startup which is announcing a $6 million seed raise today, is in this growing pack commercializing CGM tech — in its case building a subscription weight management business to target the obesity crisis.

FUNDING SEED
View Analyst & Ambassador Comments
Go to original news
Sep 23,2022

American Diabetes Association Launches Amputation Prevention Alliance

The American Diabetes Association® announced a new initiative designed to address the urgent public health challenge of preventable amputation called the Amputation Prevention Alliance. Over 135,000 amputations occur every year in the United States, with the majority of those procedures being preventable, but due to challenges in accessing quality care, patients are forced into unnecessary amputations and even death.

View Analyst & Ambassador Comments
Go to original news
Sep 23,2022

Optical Devices for Monitoring Patient Glucose Levels

Noninvasive monitors that can measure analyte levels accurately and reliably have the capability to improve disease control and patient wellbeing. By integrating the sensing element, electronics, and a power source in a single package, noninvasive monitors are creating new options for caregivers and their patients.

View Analyst & Ambassador Comments
Go to original news
Sep 23,2022

Global Diabetes Care Devices Market Analysis/Forecasts Report 2022: A $42 Billion Market by 2028 - Rapid Technological Advancements in Diabetes Care Devices

The global diabetes care devices market is expected to grow from US$ 28,942.1 million in 2022 to US$ 42,119.3 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2022 to 2028.

View Analyst & Ambassador Comments
Go to original news
Sep 26,2022

Welldoc: Delivering ‘Just in Time’ Care

Welldoc has extended its expertise in diabetes to now offer a multi-condition digital health solution across diabetes, pre-diabetes, hypertension, and heart failure, with built-in behavioral health support, a necessary element to helping individuals throughout their chronic care journey. With its mission of integrating personalized, real-time, and actionable AI-driven insights into the daily lives of individuals living with chronic conditions, Welldoc is not only focused on helping people take control of their conditions, but also on ensuring that these insights are connected to existing care models to support the right interventions and clinical decisions.

View Analyst & Ambassador Comments
Go to original news
Sep 27,2022

ASCENSIA DIABETES CARE RELAUNCHES SUCCESSFUL ‘THIS IS DIABETES’ COMPETITION IN SUPPORT OF IDF’S WORLD DIABETES DAY

Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® blood glucose monitoring (BGM) system portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring (CGM) Systems, announces that it has relaunched its successful ‘This is Diabetes’ art and photo competition in support of World Diabetes Day 2022. The competition aims to highlight the importance of diabetes care and education, amplifying the International Diabetes Federations’ (IDF’s) official theme of Access to Diabetes Care for 2021-2023, and its focus this year on Education to Protect Tomorrow.

View Analyst & Ambassador Comments
Go to original news
Sep 27,2022

Nemaura And Eversana Sign Preliminary Agreement For Large-scale Launch Of Nemaura’s Diabetes Management Program In The US

Nemaura Medical, a medical technology company focused on developing and commercialising noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces that it has entered into a preliminary agreement with EVERSANA, a pioneer of next-generation commercial services to the global life sciences industry.

COLLABORATION PARTNERSHIP

#product & service

View Analyst & Ambassador Comments
Go to original news
Sep 28,2022

Global Insulin Pump Market Report 2022: Featuring Medtronic, Insulet Corporation, Tandem Diabetes Care & Roche

According to the publisher, Global Insulin Pump Market is estimated to reach US$ 20.91 Billion by 2027. Insulin pumps are compact electronic medical devices that can be fastened to a belt, hidden in a pocket, or worn under clothing. Besides, to regulate the rise in blood glucose levels, the pump delivers controlled quantities of insulin into the body at regular intervals, based on the consumer's basal and bolus rates.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES